The Genesis Research Foundation respects your privacy. We protect your personal information and adhere to all legislative requirements with respect to privacy.
Stem cells have fascinated biologists, clinician scientists and the medical community for over a century. It’s how we all begin: stem cells develop into any one of more than 200 types of cells within the adult human body.
Stem Cells: What are they? Where are they in our body and why are they important? Where is stem cell research now and what are the opportunities for future prevention and cure? Is stem cell research a promised miracle only to dash our hopes?
There is little dispute with predictions of the tremendous potential that stem cell research holds for the future. One day stem cells may be used to replace or repair damaged cells and may have the potential to drastically change the treatment of conditions like cancer, Alzheimer's and Parkinson's diseases. The potential uses of stem cells can be limitless. Imagine the future possibilities when choosing to save your child's cord blood stem cells at birth, creating a perfect match to your baby and a probability of a match for the baby's siblings, parents or grandparents.
It’s a brave new world. However, the division over how to conduct the research has been deep and continues to be debated. Join us for an important educational forum about the most provocative and technically advanced area of medical research today.
When:
Thursday, April 24, 2008, 7:15 - 9:30 a.m.
Where:
Collaboration Centre Auditorium
MaRS Discovery District
101 College Street, Toronto
The Honourable Pamela Wallin, O.C., S.O.M., was appointed to the Senate of Canada on December 22, 2008. She is the Chancellor of the University of Guelph and she serves on several corporate boards, including CTVglobemedia, Canada’s premier multimedia company with ownership in CTV and The Globe and Mail; Gluskin Sheff & Associates, an investment and wealth management firm; Oilsands Quest, an energy development company; Porter Airlines, Canada's newest air carrier; and Jade Tower, an independent antenna site and tower company. Pamela is an Officer of the Order of Canada, and was appointed to the Independent Panel on Canada’s Future Role in Afghanistan by Prime Minister Harper in 2007. She served as Consul General of Canada in New York from 2002-2006. Pamela is the Senior Advisor on Canada-US relations at the Americas Society and the Council of the Americas in New York. She is a member of a special Advisory Board for BMO Harris Bank, a co-Chair of the National Strategy Council for the Mazankowski Alberta Heart Institute and a Board member of the Ontario Institute for Cancer Research.
Dr. Janet Rossant is the Chief of Research and Senior Scientist in Developmental and Stem Cell Biology at The Hospital for Sick Children and the Lombard Canada Insurance Chair in Paediatric Research. Dr. Rossant is a University Professor in the Departments of Medical Genetics & Microbiology, Obstetrics & Gynaecology and Paediatrics at the University of Toronto. She serves as Deputy Scientific Director of The Stem Cell Network of Canada.
Dr. Rossant is an internationally recognized world leader in mammalian developmental biology and genetics. She has received numerous prestigious awards for her contributions to the health sciences, including the 2007 March of Dimes Prize in Developmental Biology and the 2004 Killam Prize for Health Sciences. Trained at the Universities of Cambridge and Oxford, Dr. Rossant is a Fellow of the Royal Societies of both Canada and London.
Dr Joan Murphy is Associate Professor in the Department of Obstetrics and Gynecology at University of Toronto and Head of the Division of Gyn Oncology in the joint UHN/Mount Sinai Hospital Department of OB/GYN at Princess Margaret Hospital and Toronto General Hospital. She is a medical school graduate of the University of Calgary, of res- idency training at UBC and a combined fellowship at UBC and McMaster University. She has been a faculty member at UBC and at McMaster before moving to University of Toronto in 1985. Her academic activities include clinical teaching, resident and fellow training, fundraising for gynecologic cancer research, co-directing the UHN multidisciplinary Toronto Ovarian Cancer Research Network, participating in ovarian cancer research including the genetics of ovarian cancer, advancing cervical cancer screening and prevention, administration at UHN and providing tertiary-level clinical care in gyn/oncology surgery and chemotherapy. Her past activities have included directing the sub-specialty training program in Gynecologic Oncology, chairing the Clinical Quality Improvement Committee at UHN and research in HIV and cervical cancer.
